AXIM BIOTECHNOLOGIES, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Axim Biotechnologies, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2024.
  • Axim Biotechnologies, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $9.61K, a 50% decline year-over-year.
  • Axim Biotechnologies, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $93.9K, a 89.1% decline year-over-year.
  • Axim Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $198K, a 82.1% decline from 2022.
  • Axim Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.11M, a 3.17% decline from 2021.
  • Axim Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.14M, a 41.3% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $93.9K $9.61K -$9.61K -50% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $104K $9.61K -$94.2K -90.7% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-05-22
Q4 2023 $198K $36.3K -$183K -83.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $381K $38.4K -$479K -92.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $859K $19.2K -$163K -89.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $1.02M $104K -$85.1K -45% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-05-22
Q4 2022 $1.11M $219K +$308K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $799K $517K -$245K -32.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $1.04M $182K -$189K -50.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 $1.23M $189K +$89.2K +89.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $1.14M -$89K Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $762K +$347K +83.6% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-15
Q2 2021 $371K +$371K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 $99.7K Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-16
Q3 2020 $415K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.